Dr. Gaddipati has more than 20 years of experience in the oncology domain. She is a clinical oncologist and geneticist with basic science and clinical trial expertise. She holds a master’s degree from the Wharton Business School and has also served at the US FDA and National Cancer Institute. Dr Gaddipati’s expertise spans clinical, scientific, regulatory and commercialization realms of the cancer product development lifecycle. Over the past 2 decades she has treated patients with complex oncologic disorders and genetic conditions. She served as a visiting scientist in the division of molecular oncogenesis, Wistar Research Institute in Philadelphia. She gained valuable insight about the regulatory requirements for marketing approval of drugs in the division of oncology drugs products, US FDA. She brings a nuanced comprehension about the inherent challenges involved in integrating diverse expertise along the value chain. Her belief is that by addressing the inefficiencies along the translational spectrum exponential greater advancement can be achieved in cancer care.